| Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients BJ Kim, J Hyung, C Yoo, K Kim, SJ Park, SS Lee, DH Park, TJ Song, ... Cancer chemotherapy and pharmacology 80, 209-215, 2017 | 77 | 2017 |
| Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy H Cho, DH Yoon, JB Lee, SY Kim, JH Moon, YR Do, JH Lee, Y Park, ... American Journal of Hematology 92 (12), 1280-1286, 2017 | 42 | 2017 |
| Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor C Yoo, H Cho, MJ Song, SM Hong, K Kim, HM Chang, H Chae, TW Kim, ... Cancer Chemotherapy and Pharmacology 79, 139-146, 2017 | 37 | 2017 |
| Efficacy and safety of prophylactic high-dose MTX in high-risk DLBCL: a treatment intent–based analysis H Jeong, H Cho, H Kim, H Chae, JB Lee, K Lee, S Kim, S Lee, JS Ryu, ... Blood Advances 5 (8), 2142-2152, 2021 | 25 | 2021 |
| Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis H Cho, MH Ryu, K Kim, BY Ryoo, SR Park, BS Kim, IS Lee, HS Kim, ... Gastric Cancer 20, 970-977, 2017 | 17 | 2017 |
| Perioperative FLOT: new standard for gastric cancer? YK Kang, H Cho The Lancet 393 (10184), 1914-1916, 2019 | 15 | 2019 |
| Prognostic stratification of patients with Burkitt lymphoma using serum β2-microglobulin levels HD Kim, H Cho, S Kim, K Lee, EH Kang, JS Park, CS Park, J Huh, JS Ryu, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2021 | 14 | 2021 |
| Potentially inappropriate medications in elderly outpatients by the 2012 version of Beers Criteria: A single tertiary medical center experience in South Korea IY Jang, YS Lee, MK Jeon, H Cho, JS Oh, Y Lee, H Park, SH Kim, E Lee Journal of the Korean Geriatrics Society 17 (3), 126-133, 2013 | 14 | 2013 |
| Real-world data analysis of patients with cancer of unknown primary S Kang, JH Jeong, S Yoon, C Yoo, KP Kim, H Cho, BY Ryoo, J Jung, ... Scientific Reports 11 (1), 23074, 2021 | 13 | 2021 |
| Phase II study of preoperative capecitabine and oxaliplatin-based intensified chemoradiotherapy with or without induction chemotherapy in patients with locally advanced rectal … H Cho, JE Kim, K Kim, CS Yu, JC Kim, JH Kim, MA Lee, HS Jang, ST Oh, ... American Journal of Clinical Oncology 39 (6), 623-629, 2016 | 13 | 2016 |
| Prognostic implication of inflammation-based prognostic scores in patients with intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin H Cho, C Yoo, K Kim, JH Jeong, J Kang, HM Chang, SS Lee, DH Park, ... Investigational New Drugs 36, 496-502, 2018 | 12 | 2018 |
| Superiority of Epstein-Barr virus DNA in the plasma over whole blood for prognostication of extranodal NK/T cell lymphoma JY Ha, H Cho, H Sung, AR Jung, YS Lee, SW Lee, JS Ryu, EJ Chae, ... Frontiers in Oncology 10, 594692, 2020 | 11 | 2020 |
| Comprehensive evaluation of the tumor immune microenvironment and its dynamic changes in patients with locally advanced rectal cancer treated with preoperative … H Cho, JE Kim, YS Hong, SY Kim, J Kim, YM Ryu, SY Kim, TW Kim Oncoimmunology 11 (1), 2148374, 2022 | 10 | 2022 |
| Risk stratification using multivariable fractional polynomials in diffuse large B-cell lymphoma J Roh, J Jung, Y Lee, SW Kim, HK Pak, AN Lee, J Lee, J Cho, H Cho, ... Frontiers in Oncology 10, 329, 2020 | 10 | 2020 |
| BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis J Roh, H Cho, HK Pak, YS Lee, S Lee, JS Ryu, EJ Chae, KW Kim, J Huh, ... Modern Pathology 35 (4), 480-488, 2022 | 9 | 2022 |
| A prognostic index for extranodal marginal‐zone lymphoma based on the mucosa‐associated lymphoid tissue International Prognostic Index and serum β2‐microglobulin levels HD Kim, H Cho, H Jeong, K Bang, S Kim, K Lee, EH Kang, JS Park, ... British Journal of Haematology 193 (2), 307-315, 2021 | 8 | 2021 |
| Prognostic value of natural killer cell activity for patients with HER2+ advanced gastric cancer treated with first-line fluoropyrimidine–platinum doublet plus trastuzumab H Cho, MH Ryu, HE Lee, HD Kim, YK Kang Cancer Immunology, Immunotherapy, 1-10, 2022 | 7 | 2022 |
| Prognostic role of a new index tested in European and Korean advanced biliary tract cancer patients: The PECS Index G Rovesti, F Leone, G Brandi, L Fornaro, M Scartozzi, M Niger, C Yoo, ... Journal of Gastrointestinal Cancer, 1-10, 2021 | 7 | 2021 |
| Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy H Cho, DH Yoon, K Kim, KS Bae, WS Kim, HS Eom, JS Kim, JY Hong, ... Investigational New Drugs 36, 877-885, 2018 | 7 | 2018 |
| Upward trend in follicular lymphoma among the Korean population: 10-year experience at a large tertiary institution M Kim, HS Hwang, H Cho, DH Yoon, C Suh, CS Park, H Go, J Huh Journal of Pathology and Translational Medicine 55 (5), 330, 2021 | 6 | 2021 |
